This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Jado Technologies Gmbh, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Technische Universitát Dresden. Active years: 2009.
Company Filing History:
1 out of 3 
1 out of 1,330 
1 out of 100 
Years Active: 2009
Title: Marino Zerial: Innovator in Sphingolipid-Derived Pharmaceutical Compositions
Introduction
Marino Zerial is a distinguished inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on sphingolipids and their derivatives. His innovative work has the potential to impact the treatment of various disorders related to lipid rafts.
Latest Patents
Marino Zerial holds a patent for "Sphingolipid-derived pharmaceutical compositions." This invention relates to specific sphingolipids and sphingolipid derivatives that can be utilized in the preparation of medicaments aimed at treating, preventing, and ameliorating disorders associated with pathological processes in lipid rafts. He has 1 patent to his name.
Career Highlights
Throughout his career, Marino Zerial has been associated with prominent research institutions. He has worked with the Max Planck Society for the Advancement of Science and the Technische Universität Dresden. His roles in these organizations have allowed him to advance his research and contribute to the scientific community.
Collaborations
Marino Zerial has collaborated with notable colleagues, including Tobias Braxmeier and Tim Friedrichson. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Marino Zerial's work in sphingolipid-derived pharmaceutical compositions showcases his commitment to advancing medical science. His contributions are poised to make a significant impact in the field of pharmaceuticals.